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Background-—Atherosclerosis begins during preadolescence and is occurring at an accelerated rate. This acceleration has been
linked to poor lifestyle behaviors and subsequent cardiometabolic complications. Although the clustering of cardiometabolic risk
factors has been recognized for over 2 decades, previous studies in children have predominantly examined the relationships
between atherosclerosis and individual cardiometabolic risk factors or have grouped together preadolescent and adolescent
children. Further, no known studies have included glycated hemoglobin or central hemodynamic measures such as central systolic
blood pressure and augmentation index.
Methods and Results-—Principal component analysis was performed on a cross-sectional sample of 392 children (aged 9.5 years,
50% girls) from 3 representative sample sites across New Zealand. Four factors explained 60% of the variance in the measured
variables. In order of variance explained, the factors were: blood pressure (central systolic blood pressure and peripheral systolic
and diastolic blood pressure), adiposity (waist circumference, body mass index, and glycated hemoglobin), lipids (total cholesterol,
low-density lipoprotein cholesterol, and high-density lipoprotein cholesterol), and vascular (augmentation index, heart rate, and
fasting blood glucose).
Conclusions-—In accordance with previous findings in adults and adolescents, one common factor is unlikely to define
cardiometabolic health in preadolescent children. Each of the factors, except vascular, which was predominantly explained by
augmentation index, are in agreement with previous findings in adolescents. An additional novel finding was that glycated
hemoglobin and fasting blood glucose loaded onto different factors, supporting previous work suggesting that fasting blood
glucose indicates short-term glycemic control, whereas glycated hemoglobin reflects chronic glycemic control.
Clinical Trial Registration-—URL: www.anzctr.org.au/. ID: ACTRN12614000433606. ( J Am Heart Assoc. 2017;6:e007071. DOI:
10.1161/JAHA.117.007071.)
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T he clinical manifestations of cardiovascular diseasetypically appear during middle age, but the underlying
atherosclerotic process has a long asymptomatic phase of
development that often starts during early childhood, and it
seems likely that this process is occurring at an increasingly
younger age.1–3 Accelerated progression of atherosclerosis is
linked to poor lifestyle behaviors, which, in turn, also
contribute to cardiometabolic risk factors, including obe-
sity.3–5 The clustering of cardiometabolic risk factors has
been recognized for over 2 decades,6 but past studies in
children mainly explore associations between atherosclerosis
and individual cardiometabolic risk factors, rather than overall
cardiometabolic risk.1,2 Relatively few studies report details of
the clustering of components of cardiometabolic components
in children.7–14 Further, the majority of these studies group
together preadolescents and adolescents.7–10 In addition, we
were unable to identify studies of this kind that have included
glycated hemoglobin (HbA1c), central hemodynamic measures
such as central systolic blood pressure (cSBP), or a
measurement of arterial wave reflection such as the augmen-
tation index (AIx).
Studies that explore clustering of cardiometabolic risk
factors in children or adolescents have included fasting blood
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glucose (FBG),10–12 which is a standard component for
defining metabolic syndrome in adults and in children aged
10 years and older.15 However, FBG indicates short-term
glycemic control,16 whereas HbA1c reflects chronic glycemic
control.17 Findings in adults suggest that HbA1c and FBG have
different patterns of association with cardiovascular risk
profiles.18 For example, HbA1c is more strongly associated
with increased risk of cardiovascular events than FBG.19,20 We
could identify no studies that explored whether HbA1c and
FBG are differentially associated with cardiovascular risk
profiles in children.
Although past research in this area has included periph-
eral blood pressure (BP) when examining cardiometabolic
risk clustering in children,10–12 this may not accurately
reflect the effects of peak arterial BP on centrally located
organs.21 The prognostic value of cSBP has been recognized
by expert consensus,22,23 and a meta-analysis24 reports that
cSBP is more strongly associated with the risk of future
cardiovascular events than peripheral BP. Furthermore, the
degree of central pressure augmentation, AIx, also predicts
future cardiovascular events and all-cause mortality in
models that also adjust for peripheral or central BP.24,25
The advent of oscillometric pulse wave analysis devices
permit measures of cSBP and AIx relatively simply, accu-
rately,26 and precisely.27
The aims of the study reported here are to explore: (1)
underlying factors associated with individual cardiometabolic
risk factors in preadolescents using principal components
analysis; (2) the unique value of HbA1c, cSBP, and AIx in these
factors; and finally (3) the associations between being
overweight or obese in preadolescent children in relation to
these underlying factors. Considering that the atherosclerotic
process often begins during childhood, and cardiometabolic
risk factors tend to cluster, findings from this study may
enable the early identification of at-risk populations and may
help in the design of longitudinal studies of trajectories of
cardiometabolic risk.
Methods
This nonexperimental observational study was performed in
accordance with STROBE (Strengthening the Reporting of
Observational Studies in Epidemiology) guidelines.28
Participants and Study Design
Children aged between 8 and 10 years were recruited from
schools in 3 major cities in New Zealand: Wellington,
Christchurch, and Dunedin. In New Zealand, nearly all
schools are publicly funded and currently classified by the
predominant socioeconomic status of attending students in
a decile classification system. Funding for schools is partly
determined by this system so that schools with pupils from
deprived areas (decile 1) attract more funding than those
from those from wealthy areas (decile 10). In order to recruit
children from a variety of socioeconomic backgrounds,
schools within the 3 cities were stratified by high (6–10)
or low (1–5) decile, and then randomly sampled from within
these strata. Within schools, all children in the appropriate
age range were eligible for participation, except those
prescribed any cardiovascular medications or with an
orthopedic injury in the past 3 months. Parental or guardian
consent and child assent were obtained before participation,
in accordance with the requirements of the New Zealand
Health and Disability Ethics Committee (14/CEN/83). The
trial was prospectively registered with the Australia and New
Zealand Clinical Trial Registry (ACTRN12614000433606).
The data and analyses described in this article were part of
a larger cross-sectional study of the associations between
measurements of cardiac and metabolic variables and mea-
surements related to physical performance, the PACMAC (Pre-
Adolescent Cardio-Metabolic Associations and Correlates),
and details of the larger study have been previously
published.29 All measurements described in this article were
assessed in the child participants’ schools between 9 AM and
12 PM and children were asked to have been fasting for at
least 3 hours and to have refrained from exercise for
24 hours before assessment.
Clinical Perspective
What Is New?
• This study investigated the clustering of 13 cardiometabolic
variables in preadolescent children.
• Several novel cardiometabolic variables were included:
glycated hemoglobin, central blood pressure, and augmen-
tation index.
• Findings are generally in accordance with those for
adolescents and adults.
• However, the inclusion of augmentation index resulted in a
novel factor.
• Additionally, glycated hemoglobin and fasting blood glucose
loaded onto different factors.
What Are the Clinical Implications?
• One common factor is unlikely to define cardiometabolic
health in preadolescent children.
• Augmentation index is a novel risk factor.
• Glycated hemoglobin and fasting blood glucose provide
different information.
• The identified factors may enable the early identification of
at-risk populations and help in the design of longitudinal
studies.
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Anthropometric and Body Composition
Body weight was assessed to the nearest 0.05 kg using an
electric scale (A&D Instruments), with children assessed in
light clothing without shoes or other footwear, and height to
the nearest 0.1 cm with a stadiometer, with children in bare
feet (Surgical and Medical Products). Waist circumference
was measured using nonelastic tape (Seca) during midexpi-
ration at the midpoint between the lower costal margin and
the level of the anterior superior iliac crest. Hip circumference
was measured around the widest portion of the buttocks. Age-
and sex-specific body mass index (BMI) z scores were
calculated using the 2007 World Health Organization (WHO)
method,30 and children were classified as overweight or
obese if the BMI z score was greater than one SD above the
age- and sex-specific mean. This is equivalent to a BMI of
25 kg/m2 at age 19 years.30
Pulse Wave Analysis
Peripheral systolic BP (SBP), peripheral diastolic BP (DBP),
SBP, and AIx were recorded using a BP+ device (Uscom). The
BP+ device incorporates an oscillometric BP module, which
complies with the Association for the Advancement of
Medical Instrumentation (AAMI SP10) requirements and
receives an A/A rating from the British Hypertension Society
evaluation protocol.31 Following 20 minutes of undisturbed
supine rest, oscillometric pressure waveforms were recorded
in patients by a single operator on the left upper arm,
following standard manufacturer guidelines.32 Each measure-
ment cycle was 40 seconds, consisting of a brachial BP
recording and then a 10-second suprasystolic recording. A
corresponding aortic pressure waveform was generated using
a validated transfer function, from which cSBP was esti-
mated.33 AIx was calculated from the suprasystolic waveform
using the formula: AIx=(P3P0)/(P1P0), where P0 denotes
the pressure at the onset of the pulse, P1 the peak pressure of
the incident wave, and P3 the peak pressure of the reflective
wave. However, for HbA1c and glucose, along with triglycer-
ides, <40% of their variance is explained by a 4-factor model.
Cardiac and Metabolic Markers
Standard finger prick procedures were used to extract
capillary blood for measurement of fasting total cholesterol,
high-density lipoprotein cholesterol, low-density lipoprotein
cholesterol, triglycerides, serum glucose (CardioChek PA, PTS
Diagnostics),35 and HbA1c (A1CNow+, PTS Diagnostics).
36
Statistical Analysis
Statistical analyses were performed using SPSS version 22
(SPSS, Inc) and HLM6 (Scientific Software International, Inc).
The corresponding author (L.S.) had full access to the data in
the study and was responsible for the integrity of the data set
and the data analysis. Only children with full data sets were
included in the analyses.
Participant data are summarized by counts and proportions
and mean and SD for all participants and by sex.
Table 1. Participant Data Description
Categorical Variables
All (N=392) Girls (n=197) Boys (n=195)
No. (%) No. (%) No. (%)
Ethnicity
New Zealand European 279 (71) 135 (69) 144 (74)
Maori 37 (9) 21 (11) 16 (8)
Pacific 22 (6) 12 (6) 10 (5)
Not recorded 54 (14) 29 (15) 25 (13)
School year
4 82 (21) 45 (23) 37 (19)
5 114 (29) 55 (28) 59 (30)
6 127 (32) 62 (31) 65 (33)
7 69 (18) 35 (18) 34 (17)
School decile
Low (≤5) 211 (54) 106 (54) 105 (54)
High (>5) 181 (46) 91 (46) 90 (46)
Obesity status
Overweight 113 (29) 60 (30) 53 (27)
Nonoverweight 279 (71) 137 (70) 142 (73)
Continuous Variables
Mean (SD)
All (N=392)
No. (%)
Girls (n=197)
No. (%)
Boys (n=195)
No. (%)
BMI, kg/m2 17.9 (3.25) 17.9 (3.1) 17.8 (3.4)
Age, y 9.54 (1.1) 9.52 (1.16) 9.56 (1.04)
Waist circumference, cm 20.3 (9.39) 18.6 (9.1) 22 (9.37)
SBP, mm Hg 101 (7.91) 101 (8.21) 101 (7.61)
DBP, mm Hg 61.7 (6.32) 62 (6.52) 61.4 (6.11)
cSBP, mm Hg 93.2 (9.04) 93.2 (10.6) 93.3 (7.13)
Heart rate, beats/min 74.8 (11.4) 77.5 (12.1) 72 (9.87)
FBG, mmol/L 5.04 (0.38) 4.97 (0.37) 5.11 (0.38)
HbA1c, % 5.11 (0.31) 5.12 (0.32) 5.1 (0.31)
TC, mmol/L 3.55 (0.6) 3.61 (0.56) 3.49 (0.62)
HDL-C, mmol/L 1.47 (0.39) 1.42 (0.33) 1.52 (0.43)
LDL-C, mmol/L 1.85 (0.5) 1.91 (0.52) 1.79 (0.48)
TG, mmol/L 0.88 (0.42) 0.91 (0.39) 0.84 (0.45)
AIx, % 56 (15.9) 56.5 (16.7) 55.5 (15.2)
AIx indicates augmentation index; BMI, body mass index; cSBP, central systolic blood
pressure; DBP, diastolic blood pressure; FBG, fasting blood glucose; HbA1c, glycated
hemoglobin; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein
cholesterol; SBP, systolic blood pressure; TC, total cholesterol; TG, triglycerides.
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Cardiometabolic factors were derived from a principal
components analysis of the variables: SBP, DBP, cSBP, waist
circumference, BMI, triglyceride concentration, HbA1c, total
cholesterol, low-density lipoprotein cholesterol, high-density
lipoprotein cholesterol, AIx, and heart rate. The number of
factors was determined by the minimum eigenvalue principle
of a principal components analysis of the correlation matrix.
The number of factors was determined by the number of
eigenvalues >1, the implication being that if an eigenvalue is
<1, the derived dimension captures less variability in the
Table 2. Correlation Matrix of All Variables
BMI Waist SBP DBP HR FBG HbA1c TC HDL-C LDL-C TG cSBP AIx
BMI 1.000 0.773 0.262 0.146 0.024 0.124 0.101 0.098 0.218 0.072 0.238 0.168 0.201
Waist  1.000 0.307 0.240 0.011 0.125 0.151 0.071 0.208 0.019 0.222 0.205 0.201
SBP   1.000 0.756 0.259 0.139 0.099 0.052 0.026 0.051 0.067 0.736 0.003
DBP    1.000 0.243 0.048 0.144 0.016 0.015 0.018 0.072 0.660 0.116
HR     1.000 0.116 0.075 0.070 0.017 0.017 0.010 0.127 0.210
FBG      1.000 0.011 0.082 0.051 0.026 0.036 0.031 0.085
HbA1c       1.000 0.085 0.079 0.001 0.119 0.095 0.056
TC       0.085 1.000 0.467 0.501 0.035 0.005 0.021
HDL-C         1.000 0.017 0.193 0.032 0.023
TG          1.000 0.159 0.002 0.017
cSBP           1.000 0.105 0.023
cSBP            1.000 0.115
AIx             1.000
AIx indicates augmentation index; BMI, body mass index; cSBP, central systolic blood pressure; DBP, diastolic blood pressure; FBG, fasting blood glucose; HbA1c, glycated hemoglobin;
HDL-C, high-density lipoprotein cholesterol; HR, heart rate; LDL-C, low-density lipoprotein cholesterol; SBP, systolic blood pressure; TC, total cholesterol; TG, triglycerides.
Table 3. Cardiometabolic Factor Correlations and Communalities
Factor 1 Factor 2 Factor 3 Factor 4
CommunalityBlood Pressure Adiposity Lipids Vascular
SBP 0.89* 0.14 0.07 0.16 0.85
DBP 0.89* 0.04 0.00 0.04 0.80
cSBP 0.87* 0.10 0.01 0.09 0.77
Waist circumference 0.21 0.82* 0.05 0.25 0.79
BMI 0.15 0.81* 0.10 0.29 0.76
TG 0.08 0.51* 0.11 0.22 0.32
HbA1c 0.23 0.47* 0.14 0.28 0.37
TC 0.01 0.02 0.92* 0.05 0.84
LDL-C 0.01 0.03 0.71* 0.01 0.50
HDL-C 0.04 0.34 0.55* 0.02 0.42
AIx 0.20 0.16 0.07 0.74* 0.61
HR 0.28 0.16 0.07 0.57* 0.43
FBG 0.03 0.04 0.11 0.50* 0.27
Eigenvalue 2.6 2.0 1.7 1.4
Percentage of variance explained 20 15 13 11
Percentage of cumulative variance 20 35 49 60
AIx indicates augmentation index; BMI, body mass index; cSBP, central systolic blood pressure; DBP, diastolic blood pressure; FBG, fasting blood glucose; HbA1c, glycated hemoglobin;
HDL-C, high-density lipoprotein cholesterol; HR, heart rate; LDL-C, low-density lipoprotein cholesterol; SBP, systolic blood pressure; TC, total cholesterol; TG, triglycerides.
*variable loads on to factor based on loading of >0.40.
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data than any single variable. The principal components
were then subject to orthogonal “varimax” rotation and the
factor loadings, the correlation between the derived factors
and the underlying variables, were used to interpret each
factor. We used a loading of >0.40 to interpret the factor
pattern. In the event (and as described in the Results
section) we identified 4 factors representing BP, adiposity,
lipids, and vascular. From this factor structure we then
derived a cardiometabolic risk factor by summing the
individual factor scores for each individual and the 4 factors
as a summary risk score.
To determine whether overweight-obese status was asso-
ciated with heightened risk for poor cardiometabolic health,
the individual factor scores and the summary risk score were
then used as response variables in separate hierarchical linear
models. Overweight-obesity status was specified as a dummy-
coded variable (normal-weight=0, overweight-obese=1) using
the 2007 WHO criteria30 as discussed above. In these models,
we also adjusted for age, sex, ethnicity, and socioeconomic
status (as indicated by the decile of the school the
participants attended). Although the derived individual factors
and the summed risk score represent cardiometabolic
indicators, there is no natural interpretation of the differences
in these factor scores in relation to the body weight indicator
variable. Therefore, standardized effect sizes were estimated
by dividing the pooled variance by the mean difference
between groups, ie, the b for overweight-obesity. We used cut
points suggested by Cohen37 of: 0.20, 0.50, and 0.80 to
represent small, medium, and large associations, respectively.
Results
Study participants are described in Table 1. All children had
complete data sets and were included in the analyses.
Correlations among all variables are shown in Table 2,
and the factor analysis is summarized in Table 3 and the
Figure. Using the minimum eigenvalue principle, of >1, four
dimensions were retained in the factor analysis. The table
Figure. Component plots with factor diagrams from principle component analysis with varimax rotation.
AIx indicates augmentation index; cSBP, central systolic blood pressure; DBP, diastolic blood pressure;
HbA1c, glycated hemoglobin; HDL, high-density lipoprotein; HR, heart rate; LDL, low-density lipoprotein;
SBP, systolic blood pressure; whoBMI, body mass index z scores, calculated using the 2007 World Health
Organization method.
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shows the correlation of each variable with the 4 factors
and these factors are labelled: a BP factor, adiposity factor,
lipid factor, and vascular factor. Collectively, the 4 factors
explained 60% of the variance in the measured variables.
The cSBP loaded positively onto the BP factor, but no other
factor. The HbA1c loaded positively onto the adiposity
factor, whereas FBG loaded positively onto the vascular
factor. However, for HbA1c and glucose, along with
triglycerides, <40% of their variance is explained by a
4-factor model.
The associations between weight status, overweight-obese
(n=113) compared with not (n=279), with the individual factor
scores and the cumulative risk score are shown in Table 4.
Standardized effect sizes are also reported to illustrate the
strength of association, as discussed in the Methods section.
There is a medium and statistically significant association
between the cumulative risk score and overweight-obesity
status. Inspection of the individual factors reveals that, as
might be anticipated, the strongest association was between
the adiposity factor and overweight-obesity status. However,
there was also a small but statistically significant association
between the overweight-obesity status and the vascular
factor. There was no important association with the lipid or
BP factors.
Table 5 presents example linear combinations for each
factor, using one overweight and one normal-weight girl, both
of which are aged 10 years.
Discussion
The results of the analysis of cardiometabolic risk in this study
suggest that one common factor does not fully explain
cardiometabolic health in preadolescent children. Four factors
were identified, BP, adiposity, cholesterol, and vascular
factors, of which the majority of the variance was explained
by BP. Each of these factors, except vascular, which was
predominantly explained by AIx, were consistent with similar
studies conducted in children.11–14 An additional novel finding
was that HbA1c and FBG loaded onto different factors,
supporting previous work suggesting that FBG indicates short-
term glycemic control,16 whereas HbA1c reflects chronic
glycemic control.17 Lastly, we found that overweight-obese
children were more likely to have higher (worse) risk scores
for adiposity, vascular, and cumulative risk scores.
Study Strengths and Limitations
While our findings are internally robust, this study had several
potential limitations. First, the majority of the participants
were New Zealand European (white), and whether this factor
structure would generalize to other population subgroups is
unclear. Nonetheless, the proportion of Maori (9% versus
national: 14%) and Pacific (6% versus national: 7%) partic-
ipants are close to nationally representative.38 Further, past
reports from factor analysis studies with child participants
have not identified important differences in factor patterns
Table 4. Hierarchical Linear Model Associations Between Overweight-Obesity Status and Individual and Cumulative
Cardiometabolic Risk Derived From Factor Analysis
Unadjusted Adjusted
b SE P Value ES b SE P Value ES
Adiposity
Intercept 0.480 0.075 <0.001 0.473 0.079 <0.001
Overweight-obese 1.459 0.083 <0.001 1.368 1.423 0.085 <0.001 1.282
Blood pressure
Intercept 0.019 0.128 0.885 0.017 0.135 0.905
Overweight-obese 0.173 0.108 0.108 0.105 0.159 0.110 0.150 0.093
Lipids
Intercept 0.014 0.112 0.906 0.006 0.111 0.956
Overweight-obese 0.061 0.111 0.582 0.040 0.035 0.114 0.759 0.023
Vascular
Intercept 0.115 0.118 0.355 0.093 0.119 0.454
Overweight-obese 0.424 0.107 <0.001 0.274 0.403 0.109 <0.001 0.256
Cumulative
Intercept 0.569 0.184 0.013 0.566 0.198 0.019
Overweight-obese 2.008 0.194 <0.001 0.782 1.996 0.198 <0.001 0.738
Adjusted model: age, sex, ethnicity, and socioeconomic status. Effect sizes were estimated by dividing the pooled variance by the mean difference between groups. ES indicates
standardized effect size.
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based on demographic characteristics.13,14 Second, our
sample was recruited from 3 major cities and did not recruit
from rural areas, which may limit the generalizability of our
findings. However, the 3 cities were geographically varied and
wide sample zones were utilized within these regions. Third,
body composition was evaluated using typical epidemiological
measures, including BMI and waist circumference. Subse-
quent investigation is warranted utilizing assessments that
can distinguish fat and fat-free mass, such as dual-energy
x-ray absorptiometry or bioimpedance analysis. Finally, this
was a cross-sectional study, and further longitudinal studies
are needed to determine whether the identified factors
present different pathological processes.
Comparison With Other Studies
Our findings are consistent with similar studies conducted in
children,11–14 each of which identified a BP factor: 3 of which
identified a lipids/cholesterol factor11,12,14 and 2 of which
identified adiposity.11,12 For the 2 studies that did not identify
adiposity as a factor, only one adiposity variable (BMI) was
specified, which loaded onto 2 factors in one study11 and one
factor only in the other study.13 For the current analysis, 2
body composition variables were utilized (BMI and waist
circumference) and only loaded onto one factor, using a cut
point of 0.4. An additional important difference between the
current analysis and past studies is that cSBP, AIx, and HbA1c
were included in the analysis. While cSBP loaded onto the BP
factor, the interpretation is not different from previous
studies. However, AIx and HbA1c loadings do affect the
interpretation of findings.
The AIx represents central arterial wave reflection, which
depends primarily on aortic stiffness.39 In young healthy
patients, the reflected wave arrives back at the ascending
aorta during diastole, enhancing diastolic coronary perfusion.
However, as the arterial system stiffens, the pulse waves
travel faster and get reflected sooner, thereby arriving back at
the ascending aorta during systole and augmenting cSBP and
increasing afterload. The findings from this study indicate that
the AIx and BP, including cSBP, represent different constructs,
and that AIx may be an important cardiovascular measure-
ment in children. In adults, a meta-analysis24 of 11 longitu-
dinal studies (n=5648, mean follow-up 45 months) reports
that a 10% increase in AIx increases the risk of future
cardiovascular events and all-cause mortality by 32% and 38%,
respectively. In children, a limited number of studies have
Table 5. Example Linear Combinations for Each Factor Using One Overweight-Obese and One Normal-Weight Girl, Aged 10 y
Overweight (BMI: +2 SD) Normal-Weight (BMI: 2 SD)
z Score BP Adiposity Cholesterol Vascular z Score BP Adiposity Cholesterol Vascular
SBP 0.99 0.89 0.14 0.07 0.16 0.46 0.41 0.06 0.03 0.07
DBP 1.22 1.09 0.05 0.00 0.04 0.76 0.68 0.03 0.00 0.03
cSBP 0.85 0.74 0.08 0.01 0.08 0.59 0.51 0.06 0.01 0.05
Waist circumference 0.90 0.19 0.74 0.04 0.23 1.20 0.25 0.99 0.06 0.30
BMI 1.29 0.20 1.04 0.13 0.37 2.13 0.33 1.72 0.21 0.61
TG 0.10 0.01 0.05 0.01 0.02 0.42 0.04 0.21 0.05 0.09
HbA1c 0.29 0.07 0.14 0.04 0.08 0.35 0.08 0.16 0.05 0.10
TC 0.56 0.00 0.01 0.51 0.03 0.28 0.00 0.00 0.25 0.01
LDL-C 0.48 0.00 0.01 0.34 0.01 0.30 0.00 0.01 0.21 0.00
HDL-C 0.73 0.03 0.25 0.40 0.01 0.26 0.01 0.09 0.14 0.01
AIx 1.06 0.21 0.17 0.07 0.78 0.82 0.16 0.13 0.06 0.60
HR 0.02 0.01 0.00 0.00 0.01 0.37 0.11 0.06 0.03 0.21
FBG 0.37 0.01 0.01 0.04 0.19 1.15 0.04 0.04 0.13 0.58
Linear combinations by factor
BP 2.66 1.07
Adiposity 2.08 2.97
Lipids 1.35 0.27
Vascular 0.99 2.05
Factor loadings shown in Table 2. AIx indicates augmentation index; BMI, body mass index; BP, blood pressure; cSBP, central systolic blood pressure; DBP, diastolic blood pressure; FBG,
fasting blood glucose; HbA1c, glycated hemoglobin; HDL-C, high-density lipoprotein cholesterol; HR, heart rate; LDL-C, low-density lipoprotein cholesterol; SBP, systolic blood pressure; TC,
total cholesterol; TG, triglycerides.
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employed this methodology,40–44 and findings from this study
support the need to generate reference values relevant to
children.
The finding that HbA1c loaded onto the adiposity factor,
while FBG loaded onto the vascular factor, is consistent with
research identifying that the these two variables reflect
different underlying physiological constructs, with FBG
reflecting short-term glycemic control16 and HbA1c reflecting
chronic glycemic control.17 The American Heart Association
has recommended an ideal FBG of <5.55 mmol/L (100 mg/
dL) for pediatric patients,45 which was exceeded by 16%
(n=61) of the children in the current sample. However, there is
evidence to suggest that hyperinsulinism is the first metabolic
abnormality seen in obese pediatric patients, and impaired
fasting glucose occurs at a much later stage in the
progression toward type 2 diabetes mellitus.46,47 Further, in
adults, HbA1c and FBG are also differentially associated with
cardiovascular risk profiles,18 with HbA1c being more strongly
associated with increased risk of cardiovascular events than
FBG.19,20 While the findings from the current study cannot
corroborate the previous findings in adults, both the adiposity
(HbA1c) and vascular (FBG) factors were significantly worse for
overweight-obese children compared with normal-weight
children.
In the current sample, 29% (n=113) of children were
overweight-obese. This is consistent with New Zealand
national estimates of prevalence of 33%. The overweight-
obese children were more likely to have higher (worse) risk
scores for the adiposity (large effect), vascular (small effect),
and cumulative risk scores (medium effect). These differences
are striking because these children are preadolescent and
otherwise healthy. This suggests that adiposity and vascular
targets may be important for screening overweight-obese
children and refining their risk of future cardiovascular events.
Implications
This analysis indicates that the clustering of cardiometabolic
risks variables can be used to derive summary factors and a
cumulative risk score in pediatric populations. These factors
and the cumulative risk score may enable the early
identification of at-risk populations and may help in the
design of longitudinal studies of trajectories of car-
diometabolic risk.
Conclusions
The purpose of this study was to explore: (1) underlying
factors that explain cardiometabolic risk factors in preado-
lescents using principle components analysis; (2) the unique
value of HbA1c, cSBP, and AIx in these factors; and (3) the
associations between being overweight or obese in preado-
lescent children in relation to these underlying factors. Four
factors were identified, including BP, adiposity, cholesterol,
and vascular factors. Each of the factors, except vascular,
which was predominantly explained by AIx, is consistent with
similar studies conducted in children. An additional novel
finding was that HbA1c and FBG loaded onto different factors,
supporting previous work suggesting that FBG indicates short-
term glycemic control, whereas HbA1c reflects chronic
glycemic control. Lastly, we found that overweight-obese
children were more likely to have higher (worse) risk scores
for the adiposity, vascular, and cumulative risk factors. These
findings suggest that the identified factors and cumulative risk
score may enable the early identification of at-risk populations
and help in the design of longitudinal studies of trajectories of
cardiometabolic risk.
Disclosures
None.
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